ARCHIVES

FDA Commissioner Says Swifter Drug Approvals, Enforcement Emphasis Characterize ‘Today’s FDA’

This article is from The Cancer Letter archive.

Vol. 18 No. 05 | January 31, 1992

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

April 29, 2005

GAO Study Finds Lumpectomy Effective As Mastectomy In Trials And In Practice

November 25, 1994

AACR President: Cancer Program ‘Threatened,’ Calls For Strategic Plan, More Extramural Input

December 6, 1991

MUSC Hollings Cancer Center awarded NCI designation

February 1, 2021

NCI Low Fat Diet Study For Stage 2 Breast Cancer Will Include Postmenopausal Tamxifen Therapy

September 20, 1985

“Alternative” Is Misleading Term, President’s Cancer Panel Writes To Healy

February 5, 1993